different glp-1 Which works best? New meta-study puts them head-to-head Comparing Ozempic, Wegovy and Other

Because ischemic optic neuropathy can present with sudden vision loss, which may be permanent, early recognition of symptoms and prompt ophthalmologic evaluation may be especially important for patients at higher baseline risk. More than four in five cases of ischemic optic neuropathy are estimated to be the non-arteritic anterior form

Now, promising new research suggests that the same class of GLP-1 medications making headlines for weight loss and blood sugar control may also bring real relief to women who struggle with chronic migraines

from the University of Arizona

Additionally, a patient, who is a health care provider, attempted to recalculate their own dose in units and inadvertently self-administered a dose 10 times higher than intended

In their paper on the study, published in JAMA Ophthalmology , the researchers noted that the substantially increased risk of NAION observed in patients on semaglutide appears not to be due to differences in baseline characteristics between the cohorts. They proposed the possibility that expression of the GLP-1 receptor in the human optic nerve and GLP-1 RA-induced enhanced sympathetic nervous system activity might influence optic nerve head perfusion and potentially increase the risk of NAION. Another notable finding was that the greatest risk of NAION appeared to be within the first year following the prescription of semaglutide, a temporal association that supports a potential drug-induced risk of NAION, the researchers pointed out